AMED
$97.21
Revenue | $594.78Mn |
Net Profits | $61.01Mn |
Net Profit Margins | 10.26% |
PE Ratio | 35.86 |
Amedisys Inc’s revenue jumped 4.09% since last year same period to $594.78Mn in the Q1 2025. On a quarterly growth basis, Amedisys Inc has generated -0.55% fall in its revenue since last 3-months.
Amedisys Inc’s net profit jumped 323.69% since last year same period to $61.01Mn in the Q1 2025. On a quarterly growth basis, Amedisys Inc has generated 399.36% jump in its net profits since last 3-months.
Amedisys Inc’s net profit margin jumped 307.05% since last year same period to 10.26% in the Q1 2025. On a quarterly growth basis, Amedisys Inc has generated 401% jump in its net profit margins since last 3-months.
Amedisys Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 35.86.
EPS Estimate Current Quarter | 1.12 |
EPS Estimate Current Year | 1.12 |
Amedisys Inc’s earning per share (EPS) estimates for the current quarter stand at 1.12 - a -15.79% fall from last quarter’s estimates.
Amedisys Inc’s earning per share (EPS) estimates for the current year stand at 1.12.
Earning Per Share (EPS) | 0 |
Amedisys Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Amedisys Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-04-24 | 1.11 | 1.25 | 13% |
2025-10-29 | 1.12 | 0 | -100% |
2025-07-23 | 1.33 | 0 | -100% |